News

GJE client, TestCard, have won the prestigious Pitch@Palace 12.0. The competition saw 38 entrepreneurs compete in front of an influential audience of potential supporters, including CEOs, influencers, angels, mentors and business partners. TestCard is an at-home urine test kit and accompanying mobile app that turns a phone’s camera into a clinical...

OncoImmunity AS has been acquired by renowned Japanese IT and network company, NEC Corporate. OncoImmunity AS develops software that identifies neoantigen targets for truly personalized cancer vaccines, cell therapies and optimal patient selection for cancer immunotherapy clinical trials. GJE provided OncoImmunity AS with IP-related due diligence support during the acquisition...

We are delighted to have been recognised as a leading European IP firm by the Financial Times. In addition, we have received five Gold Awards for our work in the following industry sectors: Chemistry & Pharmaceuticals, Electrical Engineering, IT & Software, Materials & Nanotechnology, and Mechanical Engineering; as well as a...

We would like to congratulate Fiona Stevens and Peter Finnie for being recognised by the IAM Strategy 300: The World’s Leading IP Strategists. The unique guide lists the individuals that in-depth research has shown to possess world-class skills in the development and roll-out strategies that maximise the value of patents, copyright,...

Arnie Clarke and Peter Finnie have been recognised by Who’s Who Legal in the The Patents Agent & Attorneys 2019: Analysis. The report lists the world-leading patent attorneys who are outstanding practitioners and the very best in their field. The individuals listed received nominations and recommendations from peers, corporate counsel and other market sources. The...